US FDA staff questions Glaxo kidney cancer drug - Reuters PDF Print
ReutersVotrient, also known by its chemical name pazopanib, aims to treat advanced renal cell carcinoma. But while the company's data showed a 5-month improvement

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.